RESEARCH MONOGRAPH · KDC-MN-188

Hesperidin

May 9, 2026 Kodiac biolabs Research Revised May 30, 2026 2 min read

Our opinion on this compound

67/100

Cheap citrus flavonoid with real vascular signal but absorption that ranges from poor to embarrassing

Hesperidin is one of those compounds where the bench data is genuinely interesting and the bioavailability story keeps everything honest. It's the dominant flavanone glycoside in orange and lemon peel, and the parent aglycone hesperetin is what actually does anything pharmacologically. The glycoside form is poorly absorbed and depends heavily on gut microbiota cleaving the rutinoside before anything useful enters circulation. Thats the central problem with most of the human trial data.

Where the signal is strongest: microvascular endothelial function. The Daflon / diosmin-hesperidin combination has decades of European phlebology data behind it for chronic venous insufficiency, and the mechanism plausibly extends to general capillary fragility. NRF2 induction, mild eNOS upregulation, and a real anti-inflammatory profile in animal cardiometabolic models. We like the consistency of the vascular endpoint across studies even when the absolute effect size is small.

Where it gets thin: cognitive and neuroprotective claims. There are mouse studies showing hippocampal effects after high oral doses, but translating that to humans through 5-10 percent bioavailability of the glycoside is a stretch the literature hasn't really earned. The newer hesperetin and 2S-hesperidin formulations are interesting because they bypass the glycoside problem, but the studies are mostly sports-performance flavored and the methodology is uneven.

Sourcing is easy. It's a commodity flavonoid extracted from citrus peel waste streams, HPLC purity above 90 percent is standard, and adulteration risk is low because nobody's faking something this cheap. The downside is that vendors love to label crude extracts as hesperidin when the actual content is half rutin and half misc citrus phenolics. Get the chromatogram.

Honestly the most interesting research angle right now is the gut microbiota piece. Whether someone responds to oral hesperidin seems to depend on whether their flora can deglycosylate it efficiently, which means inter-individual variability is enormous and most negative trials might just be sampling non-responders. Thats the kind of confound that makes the literature look messier than the molecule deserves.

Worth studying? Yes, but only with the aglycone or a properly characterized 2S-hesperidin prep, and only if you're tracking actual plasma hesperetin levels. Otherwise you're just dosing peel powder.

Evidence: 55
Mechanism: 65
Reliability: 50
Safety: 90
Sourcing: 80
Value: 78
Signal: 55
Staying power: 65

Plain-language summary Intrigue 45 / 100

Hesperidin is a citrus flavonoid glycoside abundant in orange peel. It has antioxidant and vascular-protective effects. The glucosylated form (G-hesperidin) is much better absorbed than native hesperidin. Not stocked by Kodiac. This monograph is provided for research and educational reference.

Intrigue 0–100 blends mechanism novelty, evidence strength, and translational potential. Kodiac editorial, not peer-reviewed.

Citrus flavonoid glycoside

A flavanone glycoside from citrus peel with vascular and anti-inflammatory effects; the principal active in Daflon.

Abstract

Hesperidin (CAS 520-26-3; molecular formula C28H34O15; molecular weight 610.57) is a flavanone glycoside present in high concentrations in citrus peel and pith. The aglycone form (hesperetin) is the bioavailable active. The compound has documented vascular effects (improved venous tone, reduced capillary fragility) and is used clinically as part of micronized purified flavonoid fraction (MPFF, Daflon) for chronic venous insufficiency and hemorrhoids. The compound is sold as a dietary supplement. Reported research dose ranges in the literature are described in the source publications.

Mechanism of action

Flavanone glycoside; vascular tone improvement, capillary stabilization.

Reported research dose ranges

Reported research dose ranges in the literature.

References

Garner RC, et al. Pharmacokinetics of hesperetin from Daflon. Eur J Drug Metab Pharmacokinet 2002.

Read the full monograph

Available as a research-use-only PDF download. Note: PDFs for newly added compounds may take a few hours to propagate after this article was published.

KDC-MN-188

The full reference document is provided strictly for research use only. It reports research dose ranges from the published literature, not instructions for use in humans or animals.

Download PDF →

FOR RESEARCH USE ONLY. Not for medical, diagnostic, or therapeutic purposes. Not for human consumption. All information is provided for research and educational purposes only.

Kodiac sells research compounds for investigative use only.

Hesperidin

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Quick actions

Categories

Help and policies

Abstract

Mechanism of action

Reported research dose ranges

References

Read the full monograph

Adjacent monographs